rs377326213
Positions:
Variant summary
Our verdict is Uncertain significance. Variant got 5 ACMG points: 5P and 0B. PM1PM2PP3
The NM_000260.4(MYO7A):āc.3134T>Cā(p.Ile1045Thr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000104 in 1,612,884 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ā ).
Frequency
Genomes: š 0.000046 ( 0 hom., cov: 34)
Exomes š: 0.00011 ( 0 hom. )
Consequence
MYO7A
NM_000260.4 missense
NM_000260.4 missense
Scores
10
8
1
Clinical Significance
Conservation
PhyloP100: 7.66
Genes affected
MYO7A (HGNC:7606): (myosin VIIA) This gene is a member of the myosin gene family. Myosins are mechanochemical proteins characterized by the presence of a motor domain, an actin-binding domain, a neck domain that interacts with other proteins, and a tail domain that serves as an anchor. This gene encodes an unconventional myosin with a very short tail. Defects in this gene are associated with the mouse shaker-1 phenotype and the human Usher syndrome 1B which are characterized by deafness, reduced vestibular function, and (in human) retinal degeneration. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 5 ACMG points.
PM1
In a domain MyTH4 1 (size 236) in uniprot entity MYO7A_HUMAN there are 26 pathogenic changes around while only 4 benign (87%) in NM_000260.4
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.839
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MYO7A | NM_000260.4 | c.3134T>C | p.Ile1045Thr | missense_variant | 25/49 | ENST00000409709.9 | NP_000251.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MYO7A | ENST00000409709.9 | c.3134T>C | p.Ile1045Thr | missense_variant | 25/49 | 1 | NM_000260.4 | ENSP00000386331.3 | ||
MYO7A | ENST00000458637.6 | c.3134T>C | p.Ile1045Thr | missense_variant | 25/49 | 1 | ENSP00000392185.2 | |||
MYO7A | ENST00000409619.6 | c.3101T>C | p.Ile1034Thr | missense_variant | 26/50 | 1 | ENSP00000386635.2 | |||
MYO7A | ENST00000458169.2 | c.677T>C | p.Ile226Thr | missense_variant | 5/29 | 1 | ENSP00000417017.2 | |||
MYO7A | ENST00000670577.1 | n.974T>C | non_coding_transcript_exon_variant | 8/32 | ENSP00000499323.1 |
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152058Hom.: 0 Cov.: 34
GnomAD3 genomes
AF:
AC:
7
AN:
152058
Hom.:
Cov.:
34
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000137 AC: 34AN: 247390Hom.: 0 AF XY: 0.000141 AC XY: 19AN XY: 134724
GnomAD3 exomes
AF:
AC:
34
AN:
247390
Hom.:
AF XY:
AC XY:
19
AN XY:
134724
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000110 AC: 160AN: 1460826Hom.: 0 Cov.: 33 AF XY: 0.000100 AC XY: 73AN XY: 726650
GnomAD4 exome
AF:
AC:
160
AN:
1460826
Hom.:
Cov.:
33
AF XY:
AC XY:
73
AN XY:
726650
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000460 AC: 7AN: 152058Hom.: 0 Cov.: 34 AF XY: 0.0000538 AC XY: 4AN XY: 74294
GnomAD4 genome
AF:
AC:
7
AN:
152058
Hom.:
Cov.:
34
AF XY:
AC XY:
4
AN XY:
74294
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
0
ALSPAC
AF:
AC:
2
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
1
ExAC
AF:
AC:
19
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Uncertain:4
Uncertain significance, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Oct 01, 2022 | MYO7A: PP3 - |
Uncertain significance, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | May 09, 2017 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Mar 30, 2023 | Observed in homozygous state in a patient with Usher syndrome who also harbored a second homozygous variant in the MYO7A gene in the literature (Jaijo et al., 2007); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 21311020, 25049390, 17361009, 35836572) - |
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Sep 23, 2022 | This sequence change replaces isoleucine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 1045 of the MYO7A protein (p.Ile1045Thr). This variant is present in population databases (rs377326213, gnomAD 0.02%). This missense change has been observed in individual(s) with Usher syndrome (PMID: 17361009). ClinVar contains an entry for this variant (Variation ID: 501914). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt MYO7A protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Usher syndrome type 1;C1838701:Autosomal recessive nonsyndromic hearing loss 2 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Counsyl | Nov 22, 2017 | - - |
Usher syndrome type 1B Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | Natera, Inc. | Feb 20, 2020 | - - |
MYO7A-related disorder Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Sep 12, 2024 | The MYO7A c.3134T>C variant is predicted to result in the amino acid substitution p.Ile1045Thr. This variant has been reported in the homozygous state along with the MYO7A variant c.5507C>T (p.Leu1836Pro) also in the homozygous state in multiple individuals with Usher syndrome 1 (Jaijo et al. 2007. PubMed ID: 17361009; Table S3, Maltese et al. 2022. PubMed ID: 35836572). Karali M et al 2022. PubMed ID: 36460718). This variant has also been reported in a cohort study of retinal disease, but zygosity was not noted (Table S1, Karali. 2022. PubMed ID: 36460718). This variant is reported in 0.020% of alleles in individuals of European (Non-Finnish) descent in gnomAD. Although we suspect that this variant may be pathogenic, and possibly only when in cis with the variant c.5507C>T (p.Leu1836Pro), at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
Usher syndrome type 1;C1832475:Autosomal dominant nonsyndromic hearing loss 11;C1838701:Autosomal recessive nonsyndromic hearing loss 2 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Oct 09, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Uncertain
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Pathogenic
D;T;.;.;.;D
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D;D;D;D;D;D
M_CAP
Pathogenic
D
MetaRNN
Pathogenic
D;D;D;D;D;D
MetaSVM
Pathogenic
D
MutationAssessor
Pathogenic
M;.;M;.;.;.
PrimateAI
Uncertain
T
PROVEAN
Pathogenic
D;.;D;D;.;D
REVEL
Pathogenic
Sift
Uncertain
D;.;D;D;.;D
Sift4G
Uncertain
D;D;D;D;.;D
Polyphen
P;.;.;.;.;.
Vest4
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at